Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Innovative Medicines Initiative

This page shows the latest Innovative Medicines Initiative news and features for those working in and with pharma, biotech and healthcare.

Is competition the enemy of progress and collaboration the ally of success?

Is competition the enemy of progress and collaboration the ally of success?

We all appreciate that pharmaceutical companies are commercial, for-profit businesses that invest heavily in the research and development of innovative new drugs, so what is the solution? ... Looking to Europe, the Innovative Medicines Initiative (IMI)

Latest news

More from news
Approximately 4 fully matching, plus 47 partially matching documents found.

Latest Intelligence

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    EPAD is co-funded by the Innovative Medicines Initiative (IMI) and Europe’s pharma industry organisation EFPIA, and 2019 will see the first patients being treated by this groundbreaking new alliance. ... It is testament to the company’s innovative

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    She made major scientific contributions to neuroscience R&D within the pharmaceutical industry at GlaxoSmithkline, and also championed the vision for the Stevenage Bioscience Catalyst and theEuropean Innovative Medicines Initiative (IMI).

  • A quest for innovative solutions A quest for innovative solutions

    to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... The innovative Medicines Initiative (IMI), with 5.3bn invested in 90 projects, is a

  • The world is our laboratory The world is our laboratory

    In January we announced the start of phase I clinical trials in the UK and US, production of 400, 000 vaccine regimens and formation of Innovative Medicines Initiative-funded consortia to ... That said, there is a rising demand for innovative medicines

  • The Heart of the Matter 7: Reality Dawns The Heart of the Matter 7: Reality Dawns

    Likewise, European pharmacovigilance legislation implemented in 2012 means the European Medicines Agency (EMA) is now requesting post-marketing observational studies as part of its approval processes. ... In tandem, as the limitations of the

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Innovative Medicines Initiative appoints executive director Innovative Medicines Initiative appoints executive director

    Pierre Meulien joins from Genome Canada . Innovative Medicines Initiative (IMI) has named Pierre Meulien as executive director, effective from September. ... Commenting on his appointment, Meulien said: “I am delighted to have been selected to lead

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    He takes over from former UCB CEO Roch Doliveux. The Innovative Medicines Initiative (IMI) has picked Ipsen's Marc de Garidel to take over as chair of its governing board from ... Its second-phase IMI 2 programme aims to develop next generation vaccines,

  • IMI appoints new chair of scientific committee IMI appoints new chair of scientific committee

    Prof Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI).

  • Hans Lennernas joins board of CMO Recipharm Hans Lennernas joins board of CMO Recipharm

    Prof Lennernäs is currently a professor of biopharmaceuticals at Uppsala University in Sweden, where he manages an Innovative Medicines Initiative (IMI) project called OrBiTo, which aims to improve the delivery of ... We are very pleased to welcome a

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Quick links

Infographics

Multimedia